SCHOTT continues to gain US market, invests in future organic growth

RYE BROOK, NY–(BUSINESS WIRE)–SCHOTT, the international technology group and inventor of specialty glass, maintained strong growth in the United States amid global challenges in fiscal year 2021-22. The company generated sales of more than $520 million in the US, up 7% year-over-year. An additional $23 million was invested in 2022 to support organic growth, bringing the five-year investment total to nearly $75 million. Past investments delivered manufacturing efficiencies that drove success at six manufacturing sites, the research and development center, and the US headquarters.

All SCHOTT business units in the US grew, led by pharmaceutical systems, home technology and advanced optics. A major highlight for SCHOTT Pharma USA was the plan to triple the capacity of high quality pharmaceutical vials at its factory in Lebanon, PA.

“Investments in equipment and facility upgrades enabled us to overcome numerous challenges and maintain our steady progress in the US market,” said Christopher Cassidy, President of SCHOTT North America. “We have committed an additional $24 million in planned investments this year to build on our momentum. This month we opened a new diagnostic facility in Phoenix, a one-stop shop for point-of-care diagnostics that domestic production and underscores SCHOTT’s ability to be a reliable partner in the US”

The company has also made significant contributions to sustainability in 2022. SCHOTT, in particular, made the transition to 100% green energy and plans to move closer to its carbon neutrality initiative this year. In December 2022, SCHOTT laser and optical glass made a spectacular breakthrough in nuclear fusion. The National Ignition Facility (NIF) at Lawrence Livermore National Laboratory (LLNL) in California generated more energy than was consumed in a fusion reaction, opening up new possibilities for the clean energy future. SCHOTT has supplied more than 1,000 parts to the NIF and continues to play its part in the decades-long challenge of producing laser fusion power on a commercial scale.

In 2023, SCHOTT focuses on advancing its core business units and generating strong profits in the fields of med tech, aerospace and semiconductors. SCHOTT’s increased capacity to produce adaptiQ® ready-to-use vials and components for diagnostics and medical laser therapies will play a major role in advancing technology in healthcare. In addition, SCHOTT’s ultra-thin glass protects photovoltaic cells on orbiting satellites, while ZERODUR® glass-ceramics will enable never-before-seen insights with telescopes such as those at the WM Keck Observatory in Hawaii. Other special glass products such as BOROFLOAT® or fiber optic light guides support local microchip production. In the future, specialty glass may also enable advanced chip packaging designs for the most powerful microchips.

More US 2022 highlights include:

Phoenix, Arizona

  • Established 37,500 square foot diagnostic manufacturing facility in the US (Officially opened in Phoenix, AZ, on January 9, 2023)

Duryea, Pennsylvania

  • Sustained accident-free site safety record (0 lost time accidents since March 2018)

  • Used ZERODUR as mirror substrates for the DRACO imager to guide the spacecraft and provide high-resolution images on NASA’s DART mission

Southbridge, Massachusetts

  • Optical fiber for medical components boosted sales

  • Focused on operations to implement strategic productivity projects quickly and efficiently

  • More commitment to automation projects

Lebanon, Pennsylvania

  • Sales for adaptiQ® RTU vials grew as the demand for high-quality medicines, such as biologists and vaccines, increased

Pioneering. Responsible. Together.

These properties characterize SCHOTT as a manufacturer of high-tech materials based on special glass. Founder Otto Schott is considered to have invented it and became the pioneer of an entire industry. Always opening new markets and applications with a pioneering spirit and passion – that’s what has driven the #glasslovers at SCHOTT for almost 140 years. The company is represented in more than 30 countries and is a highly competent partner for high-tech industries: healthcare, home appliances and living, consumer electronics, semiconductors and datacom, optics, industrial and energy, automotive, astronomy and aerospace. In the 2022 financial year, the 17,200 employees generated a turnover of 2.8 billion euros. SCHOTT AG is owned by the Carl Zeiss Foundation, one of the oldest foundations in Germany. It uses the Group’s dividends to promote science. As a foundation company, SCHOTT has deeply embedded the responsibility for employees, society and the environment in its DNA. The goal is to be a climate neutral company by 2030.